Tech Company Financing Transactions

Sequenta Funding Round

Index Ventures and Mohr Davidow Ventures participated in a $8.5 million funding round for Sequenta. The round was announced by the company on 3/31/2012.

Transaction Overview

Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$8,460,000
Round
Undisclosed
Investors

Index Ventures (Francesco Rubertis)

Mohr Davidow Ventures (William Ericson)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
400 East Jamie Court 301
South San Francisco, CA 94080
USA
Email Address
Not Recorded
Overview
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.
Profile
Sequenta LinkedIn Company Profile
Social Media
Sequenta Company Twitter Account
Company News
Sequenta News
Facebook
Sequenta on Facebook
YouTube
Sequenta on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tom Willis
  Tom Willis LinkedIn Profile  Tom Willis Twitter Account  Tom Willis News  Tom Willis on Facebook
Chief Scientific Officer
Malek Faham
  Malek Faham LinkedIn Profile  Malek Faham Twitter Account  Malek Faham News  Malek Faham on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2012: newBrandAnalytics venture capital transaction
Next: 3/31/2012: Chain Reaction Ecommerce venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary